|
IDG, Erasmic VFs invest $3.5m in tumour
detecting machine
Perfint’s CT system simplifies procedure,
lessens risk
Bangalore, Dec. 27 IDG Ventures India and Erasmic Venture
Fund, early stage investors, on Thursday announced an investment
of $3.5 million in a start-up healthcare devices company that
has come out with a breakthrough technology involving minimum
evasive procedure to assist the CT image method to diagnose
diseases like cancer. The device, attached to a CT machine,
assists in easier and precise detection of the smallest of
tumour lesions in the lung and abdomen for an early stage
medical attention to tackle the disease. It is safer than
the current procedure which carries the risk of puncturing
an organ or tissue structures.
Perfint Healthcare Devices Pvt Ltd, a company founded by
a team of former GE Healthcare devices professional, has developed
PIGA CT, a standalone mobile needle guidance system that helps
in precise diagnosis of tumour, significantly reducing the
risk to the patient. Making it simple The device enables interventional
radiologists to attempt difficult procedures like early stage
cancer biopsy, Fine Needle Aspiration and Radio Frequency
Ablation. Estimated at $25,000, one tenth the cost in the
US, PIGA CT makes image-guided intervention far simpler, safer.
It helps timely medical attention to affected tissues.
Addressing a press conference here on Thursday, Mr Nandakumar
S, one of the founders of the Chennai-based Perfint, said
the device will be launched commercially by the first quarter
of the next financial year. Patent filed Perfint has filed
a patent for its invention in the US and India, and will focus
on developing niche healthcare products for the global market,
with a special focus on emerging markets like India and China
among others.
Perfint plans to come out with more products, including PIGA
MRI and drug delivery systems, to enlarge its product portfolio
|
